San Francisco Frontiers - Genetic testing firm 23andMe files for bankruptcy

23andMe, which sells a mail-back saliva test to determine ancestry or certain health-related genetic traits for less than $200, said late Sunday that it had "filed a voluntary petition for reorganization" with a state bankruptcy court in Missouri.

At its height a few years ago, the DNA testing craze saw millions of consumers rushing to discover their ancestry and health information with tests from 23andMe becoming popular holiday gifts.

The Silicon Valley-based company, which went public in 2021, claims 15 million customers and has seen its sales decline in recent months as the testing craze faded and the company suffered a data breach.

23andMe said that it rejected a takeover offer from its co-founder and CEO Anne Wojcicki who has resigned from her position but will remain on the company's board of directors, according to the statement.

On X, Wojcicki posted that "While I am disappointed that we have come to this conclusion and my bid was rejected, I am supportive of the company and I intend to be a bidder."

She explained that her resignation as CEO was strategic so as to "be in the best position to pursue the company as an independent bidder."

Wojcicki, who co-founded 23andMe 19 years ago, acknowledged the company's challenges but emphasized her "unwavering" belief in its future.

Faced with the difficulties, 23andMe announced the dismissal of 40 percent of its staff in November, about 200 people. It also suspended its research programs.

In a regulatory filing, 23andMe also said that it has agreed to pay approximately $37.5 million to settle claims related to the 2023 data breach.

The 2023 hacking incident saw 6.9 million accounts affected, of which 5.5 million contained information on genetic matches.

Using customers' old passwords, the hackers compromised data that included names, sex, birth year, location, photos, health information, and genetic ancestry results.

With the bankruptcy announcement, Geoffrey Fowler, a tech columnist for the Washington Post warned: "If you're one of the 15 million people who shared your DNA with 23andMe, it's time to delete your data."

He cited the risk "that your data could get sold or transferred to a new company, which might want to use it for new purposes."

The company's share price was down by nearly 50 percent to 92 cents in Monday trading on Wall Street.

D.Robinson--SFF